Challenges associated with treating children with diabetes in Saudi Arabia

Mohammed Alotaibi1, Lamia Alibrahim2, Nouf Alharbi3

  • 1Faculty of Computers and Information Technology, Tabuk University, Tabuk, Saudi Arabia.

Insights

Children with Type 1 Diabetes Mellitus (T1DM) in Saudi Arabia face challenges due to limited awareness and self-management skills. Enhanced support in schools and from the health ministry is crucial for their well-being.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Health Policy

Background:

  • Increasing prevalence of Type 1 Diabetes Mellitus (T1DM) in children in Saudi Arabia necessitates further research.
  • Limited understanding of T1DM management strategies and policies for pediatric populations.

Purpose of the Study:

  • To investigate and identify the challenges faced by children with T1DM in Saudi Arabia.

Main Methods:

  • A questionnaire-based survey was administered to child participants and their parents.
  • Multiple-choice questions assessed participants' views on T1DM management.

Main Results:

  • Deficiencies in health ministry initiatives for T1DM awareness and healthcare infrastructure.
  • Limited role of schools in providing additional care for T1DM children.
  • Children lack T1DM self-management knowledge, feel embarrassed, and are dependent on parents.

Conclusions:

  • While parental care is present, the necessity for self-management techniques is critical.
  • Children require enhanced support and education, especially during school hours, to manage T1DM effectively.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349